Institute for Translational Epidemiology

The Institute for Translational Epidemiology at the Icahn School of Medicine at Mount Sinai is the only epidemiology institute within a medical school in New York City. Positioned at the crossroads of all other medical disciplines, we play a critical role in driving interdisciplinary research in the field. Our faculty engage in highly collaborative translational and interdisciplinary research integrating population studies, novel biomarkers, genomic, and proteomic research, with the purpose of effecting changes in clinical practice and improving the treatment of disease and patient quality of life.

Our team conducts research in several areas, including cancer, mental health, palliative care and end-of-life epidemiology, microbiome and environmental epidemiology, with a crosscutting theme of tackling health disparities. Every project is completed in conjunction and collaboration with experts from the clinical and basic science departments. The Icahn School is structured to allow maximum interaction between epidemiologists and their clinical counterparts, facilitating inter-team research while at the same time increasing the chances for our faculty to be involved in clinical issues and pressing clinical questions.

We have a large number of clinical faculty with training in research methods and clinical research, which is critical to allowing epidemiologists to build methodologically sound and groundbreaking collaborative clinical projects. Moreover, results from epidemiological research projects directly translate into improved clinical practice, optimizing patient outcomes and refining personalized medicine.

Our faculty are actively engaged in training and educating medical students, residents, minority students, and faculty to increase research capacity in chronic disease epidemiology and health disparities. We recognize that to effectively address health disparities, we must cultivate a diverse workforce that reflects the communities we serve. Our commitment to diversity, equity, and inclusion is woven into every aspect of our training programs. By empowering the next generation of epidemiologists with cutting-edge skills and a deep understanding of health equity, we aim to build a workforce capable of tackling the complex health challenges of the future.

I am honored to lead the Institute, a unique environment conducive for groundbreaking work. I know that our studies will contribute to improving clinical practice, disease management, patient outcomes, and quality of life.

Emanuela Taioli, MD, PhD
Director, Institute for Translational Epidemiology
Icahn School of Medicine at Mount Sinai